Overture Orthopaedics, a privately held U.S.-based medical device company providing surgeons with innovative joint preservation solutions in sports medicine and orthopaedic surgery, announced it has achieved the $1.0M milestone in sales of its award-winning OvertureTi Knee Resurfacing System.

OvertureTi Knee Resurfacing System implants are designed specifically as an alternative when it is still too early for arthroplasty, but biological repair options are not viable for treating early osteoarthritis and focal cartilage lesions. The system is composed of femoral and tibial implants intended to be used in the partial replacement of the articular surfaces of the knee. These implants were designed with sizing options that allow the surgeon to replace only the diseased or damaged region of the joint while preserving healthy native cartilage and soft tissue. The procedure is referred to as Focalplasty.